Contact Us

Detecting lung cancer early with advanced flow cytometry

Early Detection of Cancer Saves Lives

Early Detection of Lung Cancer with Flow Cytometry

bioAffinity Technologies has developed a cost-effective, non-invasive, and accurate test called CyPath® Lung used after lung cancer screening by Low Dose CT  to detect early-stage lung cancer. Physicians can order CyPath® Lung for their patients at high risk for lung cancer.

Offices

22211 W Interstate 10
Suite 1206
San Antonio, TX 78257

Laboratories

Precision Pathology Laboratory Services 
3300 Nacogdoches Rd Ste 110
San Antonio, TX   78217
 

The Harvey Sandler Cancer Research Laboratories     
Science Research Laboratories
Suite 1.424
University of Texas San Antonio
San Antonio, TX   78249

Contact Info

info@bioaffinitytech.com
Main Office: (210) 698-5334
CyPath® Lung Sales:  Dallas Coleman
832-392-1655 or dc@bioaffinitytech.com

Investor Relations

RedChip Companies, Inc.
Dave Gentry and Barrett Boone
800-RED-CHIP (800-733-2447) or 407-491-4498
BIAF@redchip.com

Contact Us

Precision Pathology laboratory Services

Learn More about CyPath® Lung

The CyPath® Lung Flow Cytometry Test is sold by Precision Pathology Laboratory Services, a bioAffinity Technologies company,  as a Laboratory Developed Test (LDT).

CyPath® Lung is a non-invasive test that assists clinical decision-making in lung cancer patients whose low-dose computed tomography (LDCT) has demonstrated a suspicious finding.

The test reveals the lung micro-environment by automated analysis of sputum using flow cytometry to characterize cell populations indicative of cancer in the lung.

Physician Portal

Patient Portal

How to Order

CyPath® FAQ